CD38 — a new target in renal immune disease

Camponeschi, A. et al. Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. J. Exp. Med. 219, e20220201 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mayer, K. A. et al. A randomized phase 2 trial of felzartamab in antibody-mediated rejection. N. Engl. J. Med. 391, 122–132 (2024).

Article  PubMed  Google Scholar 

Hogan, K. A., Chini, C. C. S. & Chini, E. N. The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol. 10, 1187 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeidler, J. D. et al. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. Am. J. Physiol. Cell Physiol. 322, C521–C545 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boslett, J., Helal, M., Chini, E. & Zweier, J. L. Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides. J. Mol. Cell. Cardiol. 118, 81–94 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van de Donk, N. W. et al. Monoclonal antibodies targeting CD38 in hematological malignancies and beyond. Immunol. Rev. 270, 95–112 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Langer, P. et al. Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant. Cochrane Database Syst. Rev. 5, CD013595 (2024).

PubMed  Google Scholar 

Loupy, A. & Lefaucheur, C. Antibody-mediated rejection of solid-organ allografts. N. Engl. J. Med. 379, 1150–1160 (2018).

Article  CAS  PubMed  Google Scholar 

Lamarthée, B. et al. Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection. Nat. Commun. 14, 4359 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Floege, J. et al. Felzartamab (anti-CD38) in patients with IgA nephropathy — interim results from the IGNAZ study. Nephrol. Dial. Transplant. 39 (Suppl. 1), 425 (2024).

Google Scholar 

留言 (0)

沒有登入
gif